1. Home
  2. CBLL vs GAIN Comparison

CBLL vs GAIN Comparison

Compare CBLL & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CeriBell Inc.

CBLL

CeriBell Inc.

HOLD

Current Price

$21.33

Market Cap

726.2M

Sector

N/A

ML Signal

HOLD

Logo Gladstone Investment Corporation Business Development Company

GAIN

Gladstone Investment Corporation Business Development Company

HOLD

Current Price

$16.51

Market Cap

653.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBLL
GAIN
Founded
2014
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
726.2M
653.5M
IPO Year
2024
2005

Fundamental Metrics

Financial Performance
Metric
CBLL
GAIN
Price
$21.33
$16.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$23.20
$14.75
AVG Volume (30 Days)
318.6K
192.4K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
9.19%
EPS Growth
56.93
20.63
EPS
N/A
0.76
Revenue
$89,063,000.00
N/A
Revenue This Year
$29.57
$9.07
Revenue Next Year
$28.44
$7.32
P/E Ratio
N/A
$4.38
Revenue Growth
36.09
N/A
52 Week Low
$10.85
$13.14
52 Week High
$24.33
$17.14

Technical Indicators

Market Signals
Indicator
CBLL
GAIN
Relative Strength Index (RSI) 70.64 54.19
Support Level $20.39 $13.56
Resistance Level $22.28 $17.00
Average True Range (ATR) 0.89 0.43
MACD 0.32 -0.01
Stochastic Oscillator 98.70 61.13

Price Performance

Historical Comparison
CBLL
GAIN

About CBLL CeriBell Inc.

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

Share on Social Networks: